Azafaros
Latest round
- Series B
Last raised
- May 2025
Total raised
- $176M
Investors
- 7
About Azafaros
V.V. operates out of Leiden, Netherlands, concentrating on therapies for lysosomal storage disorders.V. specializes in the development of innovative therapies for lysosomal storage disorders, focusing on its lead clinical candidate, nizubaglustat. This orally available azasugar targets the central nervous system to modulate the metabolism of glycosphingolipids, essential for managing key disease pathways.Azafaros generates revenue through strategic partnerships and collaborations that support its clinical programs. These transactions typically involve agreements with healthcare institutions and pharmaceutical companies, which include upfront payments, milestone payments tied to clinical successes, and royalties on future sales of approved products. The company is targeting expansion into new markets, focusing on regions that require advanced therapeutic solutions for rare diseases. As part of its growth strategy, Azafaros aims to enhance its research and development efforts, contributing to the advancement of its clinical programs and potentially introducing new products to the market in the near future.
Who invested in Azafaros
7 investors across 3 rounds
See all investors in Azafaros
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Azafaros
Who invested in Azafaros?
Azafaros has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Azafaros raised?
Azafaros has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Azafaros last raise money?
Azafaros's most recent round on record is a Series B, in May 2025.
What does Azafaros do?
Azafaros is a pharmaceuticals company.
Where is Azafaros headquartered?
Azafaros is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Azafaros?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Azafaros's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Azafaros? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.